Presentación    
GROUP 16.
AIDS AND INFECTIOUS DISEASES
Publications

YEAR NAME I.F. CUARTILE
2012 Sobrino-Vegas, P.; Rodríguez-Urrego, J.; Berenguer, J.; Caro-Murillo, A. M.; Blanco, J. R.; Viciana, P.; Moreno, S.; Bernardino, I.; del Amo, J. Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care. ANTIVIRAL THERAPY. 2012; 17(1): 1-8. Article. 3,073  Q2
2012 García-González, C.; García-Bujalance, S.; Ruiz-Carrascoso,
G.; Arribas, J. R.; González-García, J.; Bernardino, J. I.; Pascual-
Pareja, J. F.; Martínez-Prats, L.; Delgado, R.; Mingorance, J. Detection and quantifi cation of the K103N mutation in HIV reverse transcriptase by pyrosequencing. DIAGNOSTIC
MICROBIOLOGY AND INFECTIOUS DISEASE. 2012; 72(1): 90-96. Article.
2,26 Q3
2012 Blasco, A. J.; Arribas, J. R.; Boix, V.; Clotet, B.; Domingo, P.;
González-García, J.; Knobel, H.; López, J. C.; Llibre, J. M.; Lozano, F.; Miró, J. M.; Podzamczer, D.; Santamaría, J. M.; Tuset, M.; Zamora, L.; Lázaro, P.; Gatell, J. M. Costs and costefficacy analysis of the preferred treatments by GESIDA/National plan for AIDS for the initial antiretroviral therapy in adult human Immunodefi ciency virus (HIV) infected patients in 2012. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2012; 30(6): 283-293. Article.
1,478  Q4
2012 Berenguer, J.; Pedrol, P. D.; Polo, R.; Aguirrebengoa, K.; Estrada, V.; Rodero, F. G.; Knobel, H.; Llibre, J. M.; Miralles, C.; Miró, J. M.; Rivero, A.; Santos, J.; Tuset, M.; Antela, A.; Asensi, V.; Arribas, J. R.; Blanco, J. R.; Boix, V.; Martínez, E.; García, F.; Gatell, J. M.; Mallolas, J.; Moreno, S.; Palacios, R.;
Elías, M. J. P.; Pineda, J. A.; Vidal, F.; Aldeguer, J. L. E xecutive
summary. Consensus document of GESIDA and SPNS (Spanish Secretariat for the National Plan on AIDS) regarding combined antiretroviral treatment in adults infected by the human immunodefi ciency virus (January 2012). ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2012; 30(6): 315-324. Article.
1,478 Q4
2012 Monge, S.; del Romero, J.; Rodríguez, C.; de Mendoza, C.; de
Górgolas, M.; Cosin, J.; Dronda, F.; Pérez-Cecilia, E.; Pena, J. M.; Santos, I.; Rubio, R.; del Amo, J. Socio-demographic factors associated with the progression of HIV infection and the impact of HAART in a seroconverter cohort in Madrid (1986-2009). ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA
CLÍNICA. 2012; 30(3): 117-123. Article.
 1,478 Q4
2012 Pérez-Molina, J. A.; Rillo, M. M.; Suárez-Lozano, I.; Casado-Osorio, J. L.; Cobo, R. T.; González, P. R.; Clotet, E. P.;
Hernando-Jerez, A.; Domingo, P.; Díaz, E. B.; Esteban, H.;
González-García, J. Response to combined antiretroviral
therapy according to gender and origin in a cohort of naive
HIV-infected patients: GESIDA-5808 Study. HIV CLINICAL
TRIALS. 2012; 13(3): 131-141. Article.
2,304  Q2
2012 Arribas, J. R.; Clumeck, N.; Nelson, M.; Hill, A.; van Delft, Y.; Moecklinghoff, C. The MONET trial: week 144 analysis of the effi cacy of Darunavir/Ritonavir (DRV/r) monotherapy versus DRV/r plus two nucleoside reverse transcriptase inhibitors, for patients with viral load < 50 HIV-1 RNA copies/mL at baseline. HIV MEDICINE. 2012; 13(7): 398-405. Article. 3,155  Q2
2012 Arribas, J.; Bernardino, J.; Hill, A.; Sawyer, W.; van Delft, Y.;
Moecklinghoff, C. Effects of switching to PI monotherapy on measures of lipoatrophy: meta-analysis of six randomized HIV clinical trials. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2012; 15(6): 18281. Article.
3,936  Q1
2012 Bernardino, J.; Merino, J.; Serrano, L.; Estebánez, M.; Montes,
M.; Zamora, F.; Pérez-Valero, I.; González-García, J.; Arribas, J. Longitudinal comparison of infl ammatory, coagulation and metabolic biomarkers in patients who start ART versus patients who remain ART-naive. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2012; 15(6): 18284. Article.
 3,936 Q1
2012 Arribas, J.; Pulido, F.; Hill, A.; van Delft, Y.; Moecklinghoff, C.
Predictors of long-term HIV RNA suppression on Darunavir/
Ritonavir monotherapy in the MONET trial. JOURNAL OF THE
INTERNATIONAL AIDS SOCIETY. 2012; 15(6): 18354. Article.
3,936. Q1
2012 Valero, I. P.; Letendre, S.; Ellis, R.; Deutsch, R.; Franklin, D.;
Clifford, D.; Heaton, R.; McCutchan, J.; McArthur, J.; Morgello,
S.; Gelman, B.; Collier, A.; Grant, I. Prevalence and risk factors for HIV CSF viral escape: results from the CHARTER and HNRP cohorts. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2012; 15(Suppl. 4): 18189. Article.
3,936 Q1
2012 Pérez-Valero, I.; González-Baeza, A.; Estebánez, M.; Montes,
M.; Bayón, C.; Pulido, F.; Cambron, I.; Bernardino, J.; Zamora,
F.; Monge, S.; Gaya, F.; Lagarde, M.; Rubio, R.; Hernando,
A.; González-García, J.; Arnalich, F.; Arribas, J. Prolonged
treatment with boosted protease inhibitor monotherapy is not associated with a higher rate of neurocognitive impairment than triple drug ART. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2012; 15(6): 18179. Article.
3,936 Q1
2012 van Lunzen, J.; Maggiolo, F.; Arribas, J. R.; Rakhmanova, A.; Yeni, P.; Young, B.; Rockstroh, J. K.; Almond, S.; Song, I.; Brothers, C.; Min, S. Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a doseranging, randomised, phase 2b trial. LANCET INFECTIOUS DISEASES. 2012; 12(2): 111-118. Article.  19,966  D1
2012 Pulido, F.; Arribas, J.; Hill, A.; Moecklinghoff, C. No Evidence
for evolution of protease inhibitor resistance from standard genotyping, after three years of treatment with Darunavir/Ritonavir, with or without nucleoside analogues. AIDS RESEARCH AND HUMAN RETROVIRUSES. 2012; 28(10): 1167-1169. Letter. 
2,705 Q2
2012 Pérez-Valero, I.; Cysique, L.; Letendre, S.; Heaton, R. Comments
to Garvey et al: “Low rates of neurocognitive impairment are observed in Neuro-Asymptomatic HIV-infected subjects on effective antiretroviral therapy”. HIV CLINICAL TRIALS. 2012; 13(5): 296-298. Letter.
2,304 Q2
2012 Arribas, J.; Hill, A.; Xi, N.; van Delft, Y.; Moecklinghoff, C. Interleukin-6 and C-reactive protein levels after 3 years of
 treatment with Darunavir/Ritonavir monotherapy or Darunavir/
Ritonavir plus two nucleoside reverse transcriptase inhibitors in the MONET trial. JOURNAL OF ANTIMICROBIAL
CHEMOTHERAPY. 2012; 67(7): 1804-1806. Letter. 
5,338  D1
2012 Estebánez, M.; Arribas, J. R. Protease inhibitor monotherapy:
what is its role? CURRENT HIV/AIDS REPORTS. 2012; 9(2):
179-185. Review.
No tiene No tiene
2012 Estebánez-Muñoz, M.; Stella, N.; Bernardino, J. I. HIV infection
and chronic infl ammation: Is the bacterial translocation the underlying cause? MEDICINA CLÍNICA. 2012; 138(15): 673-677. Review.
1,399 Q2
2012 Baker, J. V.; Neuhaus, J.; Duprez, D.; Freiberg, M.; Bernardino,
J. I.; Badley, A. D.; Nixon, D. E.; Lundgren, J. D.; Tracy, R.
P.; Neaton, J. D. HIV Replication, infl ammation, and the effect
of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2012; 60(2): 128-134. Article.
4,653 Q1
2012 Ramírez, M. L. M.; Pascual-Pareja, J. F.; Sánchez-Conde, M.;
de la Serna, J. I. B.; Vargas, F. X. Z.; Miralles, P.; Castro, J. M.;
Ramírez, M.; Gutiérrez, I.; González-García, J.; Berenguer, J.; López, J. R. A. Transient elastography to rule out esophageal varices and portal hypertensive gastropathy in HIV-infected individuals with liver cirrhosis. AIDS. 2012; 26(14): 1807-1812. Article. 
6,407  D1
2012 Berenguer, J.; Rodríguez, E.; Miralles, P.; Von Wichmann, M.
A.; López-Aldeguer, J.; Mallolas, J.; Galindo, MJ.; van den Eynde, E.; Téllez, M. J.; Quereda, C.; Jou, A.; Sanz, J.; Barros, C.; Santos, I.; Pulido, F.; Guardiola, J. M.; Ortega, E.; Rubio, R.; Jusdado, J. J.; Montes, M. L.; Gaspar, G.; Esteban, H.; Bellón, J. M.; González-García, J. Sustained virological response to Interferon Plus Ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus. CLINICAL INFECTIOUS DISEASES. 2012; 55(5): 728-736. Article.
9,374 D1
2012 García-Jurado, L.; Oyáguez, I.; Casado, M. A.; Tural, C.; González-
García, J.; Ortega, E.; Pineda, J. A. Evaluation of the costs of transient elastography (FibroScan (R)) in the diagnosis of liver fi brosis in HIV patients with hepatitis C virus. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2012; 30(6): 294-299. Article.
 1,478 Q4
2012 Hernando, V.; Pérez-Cachafeiro, S.; Lewden, C.; González, J.;
Segura, F.; Oteo, J. A.; Rubios, R.; Dalmáu, D.; Moreno, S.; del
Amo, J. All-cause and liver-related mortality in HIV positive subjects compared to the general population: Differences by HCV co-infection. JOURNAL OF HEPATOLOGY. 2012; 57(4): 743-751. Article.
9,858 D1
2012 Moreno, A.; Quereda, C.; Montes, M.; Pérez-Elías, M. J.; Casado, J. L.; Rodríguez-Sagrado, M. A.; Mateos, M. L.; Dronda, F.; Barcena, R.; del Campo, S.; Moreno, S. Safe coadministration of Raltegravir-based HAART in HIV-Infected patients with HCV-Cirrhosis receiving triple therapy with telaprevir or Boceprevir. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2012; 61(3): e47-e49. Letter. 4,653  Q1
2012 Guillén, S.; Prieto, L.; de Ory, S. J.; González-Granado, I.; González-Tome, M. I.; Mellado, M. J.; de José, M.; Navarro,
M. L.; Beceiro, J.; Roa, M. A.; Muñoz, M. A.; Ramos, J. T. New
diagnosis of HIV infection in children. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2012; 30(3): 131-136. Article.
1,478  Q4
2012 Díaz, L.; Méndez-Lagares, G.; Correa-Rocha, R.; Pacheco, Y.
M.; Ferrando-Martínez, S.; Ruiz-Mateos, E.; del Pozo-Balado,
M. D.; León, J. A.; Gurbindo, M. D.; de José, M. I.; Leal, M.;
Muñoz-Fernández, M. A. Detectable viral load aggravates immunosenescence features of CD8 T-Cell subsets in vertically
HIV-infected children. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2012; 60(5): 447-454.
Article.
4,653  Q1
2012 Dapena, M.; Jiménez, B.; Noguera-Julián, A.; Soler-Palacín,
P.; Fortuny, C.; Lahoz, R.; Aracil, F. J.; Figueras, C.; de José, M.
I. Metabolic disorders in vertically HIV-infected children: future
adults at risk for cardiovascular disease. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM. 2012; 25(05 jun): 529-535. Article.
0,747 Q4
2012 Briz, V.; García, D.; Méndez-Lagares, G.; Ruiz-Mateos, E.; de
Mulder, M.; Moreno-Pérez, D.; Navarro, M. L.; León-Leal, J.
A.; de José, M. I.; Ramos, J.; Mellado, M. J.; González-Tomé,
M. I.; Leal, M.; Muñoz-Fernández, M. A. High prevalence of
X4/DM-Tropic variants in children and adolescents infected
with HIV-1 by vertical transmission. PEDIATRIC INFECTIOUS
DISEASE JOURNAL. 2012; 31(10): 1048-1052. Article.  
3,569  D1
2012 Prieto, L. M.; González-Tomé, M. I.; Muñoz, E.; Fernández Ibieta, M.; Soto, B.; del Rosal, T.; Cuadrado, I.; Navarro, M.L.; Roa, M. A.; Beceiro, J.; de José, M. I.; Santos, M. J.; Lora, D.; Ramos, J. T. Low rates of mother-to-child transmission of HIV-1 and risk factors for infection in Spain: 2000-2007. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2012; 31(10): 1053-1058. Article.  3,569 D1
2012 Briz, V.; León-Leal, J. A.; Palladino, C.; Moreno-Pérez, D.; de
Ory, S. J.; de José, M. I.; González-Tomé, M. I.; Martín, C. G.;
Pocheville, I.; Ramos, J. T.; Leal, M.; Muñoz-Fernández, M. A.
Potent and sustained antiviral response of raltegravir-based highly active antiretroviral therapy in HIV type 1-infected children and adolescents. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2012; 31(3): 273-277. Article.
3,569 D1
2012 de Mulder, M.; Yebra, G.; Navas, A.; Martin, L.; de José, M. I.;
Navarro, M. L.; de Ory, S. J.; González-Granado, I.; Mellado,
M. J.; Ramos, J. T.; Holguin, A. Trends in drug resistance prevalence
in HIV-1-infected children in Madrid: 1993 to 2010 Analysis. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2012; 31(11): e213-e221. Article.
3,569 D1
2012 Vecino, R.; Santiago, B.; Baquero-Artigao, F.; López, G. L.; García, C.; Muñoz, G.; Prieto, G.; Martínez, A.; de José, M.I.; Mejias, A. Tuberculosis in pediatric solid organ and hematopoietic stem cell transplant recipients. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2012; 31(7): 774-777. Article. 3,569 D1
2012 de Mulder, M.; Yebra, G.; Navas, A.; de José, M. I.; Gurbindo,
M. D.; González-Tomé, M. I.; Mellado, M. J.; Saavedra-Lozano, J.; Muñoz-Fernández, M. A.; de Ory, S. J.; Ramos, J. T.; Holguin, A. High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain. PLOS ONE. 2012; 7(12): e52155. Article.
3,73 Q1
2012 Paño-Pardo, J. R.; Rodríguez-Bano, J.; Martínez-Sánchez, N.;
Viasus, D.; Farinas, M. C.; Leyes, M.; López-Medrano, F.; Pachón,
J.; Torre-Cisneros, J.; Oteo, J. A.; Pumarola, T.; García-Gasalla, M.; Ortega, L.; Segura, F.; Carratala, J. Prognosis of  2009 A(H1N1) infl uenza in hospitalized pregnant women in a context of early diagnosis and antiviral therapy. ANTIVIRAL THERAPY. 2012; 17(4): 719-728. Article.
3,073  Q2
2012 Viasus, D.; Cordero, E.; Rodríguez-Bano, J.; Oteo, J. A.; Fernández-Navarro, A.; Ortega, L.; Gracia-Ahufi nger, I.; Farinas,
M. C.; García-Almodóvar, E.; Payeras, A.; Paño-Pardo, J. R.;
Muñez-Rubio, E.; Carratala, J. Changes in epidemiology, clinical
features and severity of infl uenza A (H1N1) 2009 pneumonia
in the fi rst post-pandemic infl uenza season. CLINICAL MICROBIOLOGY AND INFECTION. 2012; 18(3): E55-E62. Article.
4,578 Q1
2012 Romero-Gómez, M. P.; Quiles-Melero, I.; Navarro, C.; Paño-
Pardo, J. R.; Gómez-Gil, R.; Mingorance, J. Evaluation of the
BinaxNOW PBP2a assay for the direct detection of methicillin
resistance in staphylococcus aureus from positive blood culture bottles. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS
DISEASE. 2012; 72(3): 282-284. Article.
2,26 Q3
2012 Casado-Verrier, B.; Gómez-Fernández, C.; Paño-Pardo, J.
R.; Gómez-Gil, R.; Mingorance-Cruz, J.; de Celada, R. M. A.;
Herranz-Pinto, P. Community-acquired methicillin resistant
staphylococcus aureus skin and soft tissue infections in Madrid: prevalence study. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2012; 30(6): 300-306. Article.
1,478 Q4
2012 Fernández-Ruiz, M.; Estebánez-Muñoz, M.; López-Medrano,
F.; Aguado, J. M. Iliopsoas abscess: therapeutic approach
and outcome in a series of 35 patients. ENFERMEDADES
INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2012; 30(6): 307-311. Article.
 1,478 Q4
2012 Cordero, E.; Aydillo, T.; Farinas, M. C.; Paño-Pardo, J. R.; Pachón,
J.; Viasus, D.; Riera, M.; López-Medrano, F.; Payeras, A.; Moreno, A.; Rodríguez-Bano, J.; Oteo, J. A.; Martínez-Montauti, J.; Torre-Cisneros, J.; Segura, F.; Carratala, J. Immunosuppressed
patients with pandemic infl uenza A 2009 (H1N1) virus infection. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2012; 31(4): 547-556. Article.
3,024  Q2
2012 Romero-Gómez, M. P.; Gómez-Gil, R.; Paño-Pardo, J. R.; Mingorance, J. Identifi cation and susceptibility testing of microorganism by direct inoculation from positive blood culture
bottles by combining MALDI-TOF and Vitek-2 Compact is rapid and effective. JOURNAL OF INFECTION. 2012; 65(6): 513-520. Article.
4,073 Q1
  Paño-Pardo, J. R.; Viasus, D.; Pachón, J.; Campins, A.; López-
Medrano, F.; Villoslada, A.; Gutiérrez-Cuadra, M.; Pumarola, T.; del Toro, M. D.; Oteo, J. A.; Martínez-Montauti, J.; Gutiérrez-Aroca, J.; Segura, F.; Carratala, J. Pandemic 2009 A(H1N1) infection requiring hospitalization of elderly spanish adults. JOURNAL OF THE AMERICAN GERIATRICS
SOCIETY. 2012; 60(4): 740-744. Article.
3,978 Q1
2012 García-Bujalance, S.; Navarro-San Francisco, C.; Rubio, J.
M.; Arribas, J. R.; Gutiérrez, A. Imported Plasmodium Falciparum
Malaria in HIV-infected patients: a report of two cases. MALARIA JOURNAL. 2012; 11: 136. Article.
3,4 D1
2012 Lapausa, M. R.; Pareja, J. F. P.; Pérez, M. A.; Pérez, J. L. V.;
Asensio, A. N. Outcome and treatment among patients with multidrug-resistant tuberculosis. MEDICINA CLÍNICA. 2012;
138(1): 643-649. Article.
 1,399 Q2
2012 Ramírez-Olivencia, G.; Herrero, M. D.; Subirats, M.; de Juanes,
J. R.; Peña, J. M.; Puente, S. Imported Malaria in adults. Clinical, epidemiological and analytical features. REVISTA CLÍNICA ESPAÑOLA. 2012; 212(1): 1-9. Article.
No tiene No tiene
2012 Rodríguez-Baño, J.; Paño-Pardo, J. R.; Álvarez-Rocha, L.; Asensio, A.; Calbo, E.; Cercenado, E.; Cisneros, J. M.; Cobo, J.; Delgado, O.; Garnacho-Montero, J.; Grau, S.; Horcajada, J. P.; Hornero, A.; Murillas-Angoiti, J.; Oliver, A.; Padilla, B.; Pasquau, J.; Pujol, M.; Ruiz-Garbajosa, P.; San Juan, R.; Sierra, R. Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2012; 30(1): 22-23. Editorial Material.  1,478 Q4
2012 Suárez-García, I.; Paño-Pardo, J. R.; Noguerado, A. Multidrug-
resistant tuberculous spondylitis. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2012; 30(7): 424-245. Letter.
1,478 Q4
2012 Sendagorta, E.; Vidaurrazaga, C.; Mulekyo, R. Hyperpigmented
plaque on the foot of a kenyan patient. ACTAS DERMOSIFILIOGRÁFICAS. 2012; 103(7): 633-634. Article.
N/A N/A
2012 Ramírez, P.; Feito, M.; Sendagorta, E.; González-Beato, M.; de Lucas, R. Childhood actinic lichen planus: Successful  treatment with antimalarials. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2012; 53(1): e10-e13. Article. 0,965.  Q3
2012 Ramírez-Olivencia, G.; Herrero, M. D.; Subirats, M.; de Juanes,
J. R.; Peña, J. M.; Puente, S. Imported Malaria and HIV infection in Madrid. Clinical and epidemiological features. REVISTA CLÍNICA ESPAÑOLA. 2012; 212(1): 10-17. Article.
No tiene No tiene
2012 Puig, J. G.; Alonso-Vega, G. G.; Blanco, J. J. R. Report of the
editors, 2011. REVISTA CLÍNICA ESPAÑOLA. 2012; 212(1): 31-39. Article.
No tiene No tiene
2012 Blanco, J. J. R.; Suñe, N. M.; Pellicer, J. A.; Hernandez, F.J. B. Anti-neutrophil cytoplasmic antibodies: beyond vasculitis. MEDICINA CLÍNICA. 2012; 139(3): 137-138. Letter. 1,399  Q2
2012 Martín-Suñe, N.; Ríos-Blanco, J. J. Pulmonary affectation
of Vasculitis. ARCHIVOS DE BRONCONEUMOLOGÍA. 2012;
48(11): 410-418. Review.
1,372  Q4
2012 Estebánez-Muñoz, M.; Soto-Abanades, C. I.; Ríos-Blanco, J.J.; Arribas, J. R. Updating our understanding of pulmonary disease associated with HIV infection. ARCHIVOS DE BRONCONEUMOLOGÍA. 2012; 48(4); 126-132. Review.  1.372 Q4
2012 Simeón-Aznar, C. P.; Fonollosa-Pla, V.; Tolosa-Vilella, C.; Espinosa-Garriga, G.; Ramos-Casals, M.; Campillo-Grau, M.;
García-Hernandez, F.; Castillo-Palma, M. J.; Saáchez-Román,
J.; Callejas-Rubio, J. L.; Ortego-Centeno, N.; Egurbide-Arberas,
M. V.; Trapiellla-Martínez, L.; Gallego-Villalobos, M.; Sáez-Comet, L.; Velilla-Marco, J.; Camps-García, M. T.; de ramon-Garrido, E.; Marcos, E. M. E.; Pallares-Ferreres, L.; Hidalgo-Tenorio, C.; Sabio-Sánchez, J. M.; Gómez-de la Torre, R.; Salvador-Cervello, G.; Ríos-Blanco, J. J.; Gil-Aguado, A.; Vilardell-Tarres, M. Registry of the spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2012; 41(6): 789-800. Review.
3,806 Q2
2011 Llibre, J. M.; Arribas, J. R.; Domingo, P.; Gatell, J. M.; Lozano, F.; Santos, J. R.; Rivero, A.; Moreno, S.; Clotet, B. Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy. AIDS. 2011; 25(14): 1683-1690. Article. 6,245 D1
2011 Pulido, F.; Arribas, J. R.; Hill, A.; Van Delft, Y.; Moecklinghoff, C. Analysis of drug resistance during HIV RNA viraemia in the MONET trial of darunavir/ritonavir monotherapy. ANTIVIRAL THERAPY. 2011; 16(1): 59-65. Article. 3,161 Q2
2011 McKinnon, J. E.; Delgado, R.; Pulido, F.; Shao, W.; Arribas, J. R.; Mellors,
J. W. Single genome sequencing of HIV-1 gag and protease resistance mutations at virologic failure during the OK04 trial of simplified versus standard maintenance therapy. ANTIVIRAL THERAPY. 2011; 16(5): 725-732. Article.
3,161 Q2
2011 Lejeune, M.; Miro, J. M.; De Lazzari, E.; García, F.; Claramonte, X.;
Martínez, E.; Ribera, E.; Arrizabalaga, J.; Arribas, J. R.; Domingo,
P.; Ferrer, E.; Plana, M.; Valls, M. E.; Podzamczer, D.; Pumarola, T.;
Jacquet, A.; Mallolas, J.; Gatell, J. M.; Gallart, T. Restoration of T
Cell Responses to Toxoplasma gondii after Successful Combined
Antiretroviral Therapy in Patients with AIDS with Previous Toxoplasmic Encephalitis. CLINICAL INFECTIOUS DISEASES. 2011; 52(5): 662-670. Article.
9,154 D1
2011 Pérez-Valero, I.; Arribas, J. R. Protease inhibitor monotherapy. CURRENT OPINION IN INFECTIOUS DISEASES. 2011; 24(1): 7-11. Review. 4,93 Q1
2011 Pérez-Molina, J. A.; Suárez-Lozano, I.; del Arco, A.; Teira, R.; Bachiller,
P.; Pedrol, E.; Martínez-Alfaro, E.; Domingo, P.; Marino, A.; Ribera, E.; Antela, A.; de Otero, J.; Navarro, V.; González-García, J. Late Initiation of HAART Among HIV-Infected Patients in Spain Is Frequent and Related to a Higher Rate of Virological Failure but not to Immigrant Status. HIV CLINICAL TRIALS. 2011; 12(1): 1-8. Article.
1,638 Q3
2011 Clumeck, N.; Rieger, A.; Denes, B.; Schmidt, W.; Hill, A.; Van Delft,
Y.; Moecklinghoff, C.; Arribas, J. 96 week results from the MONET
trial: a randomized comparison of darunavir/ritonavir with versus without nucleoside analogues, for patients with HIV RNA < 50 copies/mL at baseline. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2011; 66(8): 1878-1885. Article. 5,068. D1
5,068 D1
2011 Imaz, A.; Llibre, J. M.; Mora, M.; Mateo, G.; Camacho, A.; Blanco,
J. R.; Curran, A.; Santos, J. R.; Caballero, E.; Bravo, I.; Gaya, F.;
Domingo, P.; Rivero, A.; Falco, V.; Clotet, B.; Ribera, E. Efficacy
and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2011; 66(2): 358-362. Article.
5,068 D1
2011 Eron, J. J.; Rockstroh, J. K.; Reynes, J.; Andrade-Villanueva, J.; Ramalho-Madruga, J. V.; Bekker, L. G.; Young, B.; Katlama, C.; Gatell-Artigas, J. M.; Arribas, J. R.; Nelson, M.; Campbell, H.; Zhao, J.; Rodgers, A. J.; Rizk, M. L.; Wenning, L.; Miller, M. D.; Hazuda, D.; DiNubile, M. J.; Leavitt, R.; Isaacs, R.; Robertson, M. N.; Sklar, P.; Nguyen, B. Y. Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial. LANCET INFECTIOUS DISEASES. 2011; 11(12): 907-915. Article. 17,391 D1
2011 Mathis, S.; Khanlari, B.; Pulido, F.; Schechter, M.; Negredo, E.; Nelson,
M.; Vernazza, P.; Cahn, P.; Meynard, J. L.; Arribas, J.; Bucher, H. C. Effectiveness of Protease Inhibitor Monotherapy versus Combination Antiretroviral Maintenance Therapy: A Meta-Analysis. PLOS ONE. 2011; 6(7): e22003. Article.
4,092. Q1
2011 Panel de expertos de GESIDA y Plan Nacional sobre el Sida (Arribas López, J. R.) .National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update). ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2011; 29(3): e1-e103. Article. 1,491 Q3
2011 Bernardino, J. I.; Mora, M.; Zamora, F. X.; Arribas, B.; Montes, M.
L.; Pascual-Pareja, F.; San José, B.; Peña, J. M.; Arribas, J. R. Hypertension and Isolated Office Hypertension in HIV-Infected Patients
Determined By Ambulatory Blood Pressure Monitoring: Prevalence and Risk Factors. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2011; 58(1): 54-59. Article.
4,425 Q1
2011 Berenguer, J.; von Wichmann, M. A.; Quereda, C.; Miralles, P.; Mallolas, J.; López-Aldeguer, J.; Álvarez-Pellicer, J.; De Miguel, J.; Crespo, M.; Guardiola, J. M.; Téllez, M. J.; Galindo, M. J.; Arponen, S.; Barquilla, E.; Bellón, J. M.; González-García, J. Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2011; 66(12):2843-2849. Article. 5,068. D1
2011 Sánchez-Conde, M.; Ramírez, M. L. M.; Cano, J. M. B.; Caminoa, A.; Rodríguez, F. A.; García, J. G.; Martín, P. M.; de la Serna, I. B.; de Quiros, J. C. L. B.; López, J. R. A.; Ochaita, J. C.; Pareja, J. F. P.; Álvarez, E.; Berenguer, J. B. Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus. JOURNAL OF VIRAL HEPATITIS. 2011; 18(7): E278-E283. Article. 4,088 Q1
2011 López-Diéguez, M.; Montes, M. L.; Pascual-Pareja, J. F.; Quereda, C.; Von Wichmann, M. A.; Berenguer, J.; Tural, C.; Hernando, A.; González-García, J.; Serrano, L.; Arribas, J. R. The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients. AIDS. 2011; 25(7): 899-904. Article. 6,245 D1
2011 Tuma, P.; Pineda, J. A.; Labarga, P.; Vidal, F.; Rodríguez, C.; Poveda,
E.; Santos, J.; González-García, J.; Sobrino, P.; Tural, C.; Soriano,
V. HBV primary drug resistance in newly diagnosed HIV-HBVcoinfected
individuals in Spain. ANTIVIRAL THERAPY. 2011; 16(4): 585-589. Article.
3,161 Q2
2011 Pérez-Valero, I.; Bayón, C.; Cambrón, I.; González, A.; Arribas, J. R.
Protease inhibitor monotherapy and the CNS: peace of mind? JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2011; 66(9): 1954-1962. Review.
5,068 D1
2011 Merino, J. J.; Montes, M. L.; Blanco, A.; Bustos, M. J.; Oreja-Guevara,
C.; Bayón, C.; Cuadrado, A.; Lubrini, G.; Cambron, I.; Muñoz, A.; Cebolla, S.; Gutiérrez-Fernández, M.; Bernardino, J. I.; Arribas, J. R.;
Fiala, M. HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system. REVISTA DE NEUROLOGÍA. 2011; 52(2): 101-111. Article.
0,652 Q4
2011 Briz, V.; Palladino, C.; Navarro, M. L.; de Ory, S. J.; González-Tome, M.I.; León, J. A.; Núñez-Cuadros, E.; de José, M. I.; Ramos, J. T.; Muñoz-Fernández, M. A. Etravirine-based highly active antiretroviral therapy in HIV-1-infected paediatric patients. HIV MEDICINE. 2011; 12(7):442-446. Article 3,006 Q2
2011 Nso, A. P.; Larru, B.; Bellón, J. M.; Mellado, M. J.; Ramos, J. T.; González, M. I.; Navarro, M. L.; Muñoz-Fernández, M. A.; de José, M. I.HIV-Infected Adolescents: Relationship Between Atazanavir Plasma
Levels and Bilirubin Concentrations. JOURNAL OF ADOLESCENT
HEALTH. 2011; 48(1): 100-102. Article.
3,334 D1
2011 Palladino, C.; Climent, F. J.; de José, M. I.; De Ory, S. J.; Bellón, J. M.;
Guillen, S.; Gurbindo, M. D.; González-Tome, I.; Mellado, M. J.; Pérez,
J. M.; Calvo, C.; Ramos, J. T.; Muñoz-Fernández, M. A. Causes of Death in Pediatric Patients Vertically Infected by the Human Immunodeficiency Virus Type 1 in Madrid, Spain, From 1982 to Mid-2009. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2011; 30(6): 495-500. Article.
3,577 D1
2011 Viasus, D.; Paño-Pardo, J. R.; Cordero, E.; Campins, A.; López-Medrano, F.; Villoslada, A.; Farinas, M. C.; Moreno, A.; Rodríguez-Bano, J.; Oteo, J. A.; Martínez-Montauti, J.; Torre-Cisneros, J.; Segura, F.; Carratala, J. Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia. JOURNAL OF INFECTION. 2011; 62(3): 193-199. Article. 4,126 Q1
2011 Paño-Pardo, J. R.; Martín-Quiros, A.; Romero-Gómez, M.; Maldonado,
J.; Martín-Vega, A.; Rico-Nieto, A.; Mora-Rillo, M.; Grill, F.; García-
Rodríguez, J.; Arribas, J. R.; Carratala, J.; Rodríguez-Bano, J. Perspectives from Spanish infectious diseases professionals on 2009 A (H1N1) influenza: the third half. CLINICAL MICROBIOLOGY AND INFECTION. 2011; 17(6): 845-850. Article.
4,54 Q1
2011 Viasus, D.; Paño-Pardo, J. R.; Pachón, J.; Campins, A.; López-Medrano, F.;Villoslada, A.; Farinas, M. C.; Moreno, A.; Rodríguez-Bano, J.; Oteo, J. A.; Martínez-Montauti, J.; Torre-Cisneros, J.; Segura, F.; Gudiol, F.; Carratala, J. Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. CLINICAL MICROBIOLOGY AND INFECTION. 2011; 17(5): 738-746. Article. 4,54 Q1
2011 Viasus, D.; Paño-Pardo, J. R.; Pachn, J.; Riera, M.; López-Medrano, F.;
Payeras, A.; Farinas, M. C.; Moreno, A.; Rodríguez-Bano, J.; Oteo, J. A.; Ortega, L.; Torre-Cisneros, J.; Segura, F.; Carratala, J. iming of Oseltamivir Administration and Outcomes in Hospitalized Adults With Pandemic 2009 Influenza A(H1N1) Virus Infection. CHEST. 2011; 140(4): 1025-1032. Article.
5,25 D1
2011 Llorente, A.; Pérez-Valero, I.; García, E.; Heras, I.; Fraile, V.; García,
P.; López, J.; Salavert, M.; Bobillo, F. Mortality risk factors in patients
with zygomycosis: a retrospective and multicentre study of 25 cases.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2011; 29(4): 263-268. Article.
1,491 Q3
2011 Paño-Pardo, J. R.; Padilla, B.; Romero-Gómez, M. P.; Moreno-Ramos,
F.; Rico-Nieto, A.; Mora-Rillo, M.; Horcajada, J. P.; Arribas, J. R.; Rodríguez-Bano, J. Monitoring activities and improvement in the use of
antibiotics in Spanish hospitals: results of a national survey. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2011; 29(1): 19-25. Article.
1,491 Q3
2011 Paño-Pardo, J. R.; Martínez-Sánchez, N.; Martín-Quirós, A.; Romero-
Gómez, M. P.; Muñoz-Muñiz, M.; Sánchez-Pastor, M.; Ruiz, G.; San-José, B.; Prados, M. C.; Mora-Rillo, M.; Rico-Nieto, A.; Arribas, J. R. Influenza-like illness in pregnant women during summertime: clinical, epidemiological and microbiological features. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2011; 30(12): 1497-1502. Article.
2,859 Q2
2011 Fernández, E. R.; Pardo, J. R. P.; Doyle, A.; Albendea, M. C.; de la Rua, A. R. Hemophagocytic syndrome associated NK/T nasal type lymphoma presenting as hypereosinophilic syndrome: A case report and literature review. LEUKEMIA RESEARCH. 2011; 35(7): E97-E99. Article. Letter. 2,923 Q2
2011 Viasus, D.; Paño-Pardo, J. R.; Pachón, J.; Riera, M.; López-Medrano,
F.; Payeras, A.; Farinas, M. C.; Moreno, A.; Rodríguez-Bano, J.; Oteo,
J. A.; Martínez-Montauti, J.; Torre-Cisneros, J.; Segura, F.; Gudiol, F.;
Carratala, J. Pneumonia Complicating Pandemic (H1N1) 2009 Risk Factors, Clinical Features, and Outcomes. MEDICINE. 2011; 90(5): 328-336. Article.
4,35 Q1
2010 Sánchez-Conde, M.; Montes-Ramírez, M. L.; Miralles, P.; Álvarez, J. M.; Bellón, J. M.; Ramírez, M.; Arribas, J. R.; Gutiérrez, I.; López, J. C.; Cosín, J.; Álvarez, E.; González, J; Berenguer, J. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. JOURNAL OF VIRAL HEPATITIS. 2010; 17(4): 280-286. Article. 3,502 Q2
2010 Rodríguez-Vila, B.; Gaya, F.; García-Vicente, F.; Gómez, E. J. Three-dimensional quantitative evaluation method of nonrigid registration algorithms for adaptive radiotherapy. MEDICAL PHYSICS. 2010; 37(3): 1137-1145. Article. 3,07 Q1
2010 Miro, J. M.; Manzardo, C.; Pich, J.; Domingo, P.; Ferrer, E.; Arribas, J. R.; Ribera, E.; Arrizabalaga, J.; Lonca, M.; Cruceta, A.; de Lazzari, E.; Fuster, M.; Podzamczer, D.; Plana, M.; Gatell, J. M. Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV Type 1-Infected Patients Using a Nonnucleoside Reverse Transcriptase Inhibitor-Based or a Boosted Protease Inhibitor-Based Antiretroviral Regimen: Three-Year Results (The Advanz Trial): A Randomized, Controlled Trial. AIDS RESEARCH AND HUMAN RETROVIRUSES. 2010; 26(7): 747-757. Article. 2,082 Q3
2010 González-García, J.; Cohen, D.; Johnson, M.; Sloan, L.; Fredrick, L.; Naylor, C.; da Silva, B.; Bernstein, B. Short Communication: Comparable Safety and Efficacy with Once-Daily Versus Twice-Daily Dosing of Lopinavir/Ritonavir Tablets with Emtricitabine plus Tenofovir DF in Antiretroviral-Naive, HIV Type 1-Infected Subjects: 96 Week Final Results of the Randomized Trial M05-730. AIDS RESEARCH AND HUMAN RETROVIRUSES. 2010; 26(8): 841-845. Article. 2,082 Q3
2010 Rubio, R.; Serrano, O.; Carmena, J.; Asensi, V.; Echevarria, S.; Flores, J.; Ribera, E.; Zarraga, M.; Ocampo, A.; de la Fuente, B.; Sepulveda, M. A.; Marino, A. I.; Mínguez, C.; Vicent, R.; Carton, J. A.; Moyano, B.; Esteban, H.; Mahillo, B.; Serrano, L.; González-García, J. Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditions. HIV MEDICINE. 2010; 11(9): 545-553. Article. 3,575 Q2
2010 Resino, S.; Palladino, C.; Lorente, R.; Micheloud, D.; Bellón, J. M.; Larru, B.; Gutiérrez, M. D. G.; de Jose, M. I.; Polo, R.; Muñoz-Fernández, M. A. Association between lipodystrophy and leptin in human immunodeficiency virus-1-infected children receiving lopinavir/ritonavir-based therapy. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2010; 29(8): 774-777. Article. 3,064 Q1
2010 Guillén, S.; San Miguel, L. G.; Resino, S.; Bellón, J. M.; González, I.; de Ory, S. J.; Muñoz-Fernández, M. A.; Navarro, M. L.; Gurbindo, M. D.; de José, M. I.; Mellado, M. J.; Martín-Fontelos, P.; González-Tomé, M. I.; Martínez, J.; Beceiro, J.; Roa, M. A.; Ramos, J. T. Opportunistic infections and organ-specific diseases in HIV-1-infected children: a cohort study (1990-2006). HIV MEDICINE. 2010; 11(4): 245-252. Article. 3,575 Q2
2010 Arribas, J. R.; Horban, A.; Gerstoft, J.; Fatkenheuer, G.; Nelson, M.; Clumeck, N.; Pulido, F.; Hill, A.; van Delft, Y.; Stark, T.; Moecklinghoff, C. The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml. AIDS. 2010; 24(2): 223-230. Article. 6,348 Q1
2010 Palladino, C.; Briz, V.; Policarpo, S. N.; Silveira, L. F.; de Jose, M. I.; González-Tome, M. I.; Moreno, D.; Leal, J. A. L.; Mellado, M. J.; de Ory, S. J.; Ramos, J. T.; Muñoz-Fernández, M. A. Long-term efficacy and safety of fosamprenavir in human immunodeficiency virus-infected pediatric patients. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2010; 29(6): 563-566. Article. 3,064 Q1
2010 Boer, K.; England, K.; Godfried, M. H.; Thorne, C.; Newell, M. L.; Mahdavi, S.; Giaquinto, C.; Rampon, O.; Mazza, A.; De Rossi, A.; Worner, I. G.; Mok, J.; de José, M. I.; Martínez, B. L.; Peña, J. M.; García, J. G.; López, J. R. A.; Rodríguez, M. C. G.; Asensi-Botet, F.; Otero, M. C.; Pérez-Tamarit, D.; Scherpbier, H. J.; Kreyenbroek, M.; Godfried, M. H.; Nellen, F. J. B.; Naver, L.; Bohlin, A. B.; Lindgren, S.; Kaldma, A.; Belfrage, E.; Levy, J.; Barlow, P.; Manigart, Y.; Hainaut, M.; Goetghebuer, T.; Brichard, B.; De Bruycker, J. J.; Thiry, N.; Waterloos, H.; Viscoli, C.; De María, A.; Bentivoglio, G.; Ferrero, S.; Gotta, C.; Mur, A.; Paya, A.; López-Vílchez, M. A.; Carreras, R.; Valerius, N. H.; Rosenfeldt, V.; Coll, O.; Suy, A.; Pérez, J. M.; Fortuny, C.; Boguna, J.; Savasi, V.; Fiore, S.; Crivelli, M.; Vigano, A.; Giacomet, V.; Cerini, C.; Raimondi, C.; Zuccotti, G.; Alberico, S.; Tropea, M.; Businelli, C.; Taylor, G. P.; Lyall, E. G. H.; Penn, Z.; Buffolano, W.; Tiseo, R.; Martinelli, P.; Sansone, M.; Maruotti, G.; Agangi, A.; Tibaldi, C.; Marini, S.; Masuelli, G.; Benedetto, C.; Niemiec, T.; Marczynska, M.; Dobosz, S.; Popielska, J.; Oldakowska, A.; Malyuta, R.; Semenenko, I.; Pilipenko, T. Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe. HIV MEDICINE. 2010; 11(6): 368-378. Article. 3,575 Q2
2010 Palladino, C.; Briz, V.; González-Tome, M. I.; Leal, J. A. L.; Navarro, M. L.; de José, M. I.; Ramos, J. T.; Muñoz-Fernández, M. A. Short Communication: Evaluation of the Effect of Enfuvirtide in 11 HIV-1 Vertically Infected Pediatric Patients Outside Clinical Trials. AIDS RESEARCH AND HUMAN RETROVIRUSES. 2010; 26(3): 301-305. Article. 2,082 Q3
2010 Rybniker, J.; Goede, V.; Mertens, J.; Ortmann, M.; Kulas, W.; Kochanek, M.; Benzing, T.; Arribas, J. R.; Fatkenheuer, G. Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure - a case report and brief review of the literatura. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2010; 14(6): E522-E525. Article. 2,529 Q3
2010 Nso-Roca, A. P.; Larru, B.; Bellón, J. M.; Mellado, M. J.; Ramos, J. T.; González, M. I.; Navarro, M. L.; Muñoz-Fernández, M. A.; de Jose, M. I. Plasma antiretroviral levels in children with human immunodeficiency virus infection. Influence of sex and age. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2010; 28(5): 278-283. Article. 1,656 Q3
2010 Nso, A. P.; Larru, B.; Bellón, J. M.; Mellado, M. J.; Ramos, J. T.; González, M. I.; Navarro, M. L.; Muñoz-Fernández, M. A.; de José, M. I. Comparison of levels of antiretroviral drugs with efficacy in children with HIV infection. INDIAN JOURNAL OF PEDIATRICS. 2010; 77(4): 397-402. Article. 0,502 Q4
2010 Lifson, A. R.; Neuhaus, J.; Arribas, J. R.; van den Berg-Wolf, M.; Labriola, A. M.; Read, T. R. H. Smoking-Related Health Risks Among Persons With HIV in the Strategies for Management of Antiretroviral Therapy Clinical Trial. AMERICAN JOURNAL OF PUBLIC HEALTH. 2010; 100(10): 1896-1903. Article. 3,85 Q1
2010 Stellbrink, H. J.; Orkin, C.; Arribas, J. R.; Compston, J.; Gerstoft, J.; Van Wijngaerden, E.; Lazzarin, A.; Rizzardini, G.; Sprenger, H. G.; Lambert, J.; Sture, G.; Leather, D.; Hughes, S.; Zucchi, P.; Pearce, H. Comparison of Changes in Bone Density and Turnover with Abacavir-Lamivudine versus Tenofovir-Emtricitabine in HIV-Infected Adults: 48-Week Results from the ASSERT Study. CLINICAL INFECTIOUS DISEASES. 2010; 51(8): 963-972. Article. 8,16 Q1
2010 Pérez-Molina, J. A.; Rillo, M. M.; Suárez-Lozano, I.; Osorio, J. L. C.; Cobo, R. T.; González, P. R.; Clotet, E. P.; Jérez, A. H.; Pedrol, P. D.; Royuela, A.; Díaz, E. B.; Esteban, H.; González-García, J. Do HIV-Infected Immigrants Initiating HAART have Poorer Treatment-Related Outcomes than Autochthonous Patients in Spain? Results of the GESIDA 5808 Study. CURRENT HIV RESEARCH. 2010; 8(7): 521-530. Article. 1,923 Q3
2010 Ibieta, M. F.; Cano, J. M. B.; Amador, J. T. R.; González-Tome, M. I.; Martín, S. G.; Gómez, M. N.; de José, M. I.; Beceiro, J.; Iglesias, E.; Prieto, L.; Santos, M. J.; Guardía, N. M.; Roa, M. A.; Regidor, J. In-utero Antiretroviral exposure and mitochondrial toxicity in a cohort of uninfected infants born to HIV-1-infected women. ANALES DE PEDIATRÍA. 2010; 73(4): 180-188. Article. 0,57 Q4
2010 Estebánez-Muñoz, M.; Montes, M. L.; Ruiz-Seco, P.; Royo-Orejas, A.; González-García, J.; Arribas, J. R. Demyelinating disease in human immunodeficiency virus-infected patients without severe immunodepression. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2010; 28(9): 608-611. Article. 1,656 Q3
2010 Winston, A.; Fatkenheuer, G.; Arribas, J.; Hill, A.; van Delft, Y.; Moecklinghoff, C. Neuropsychiatric adverse events with ritonavir-boosted-darunavir-monotherapy in HIV-infected individuals, a randomised prospective study. HIV CLINICAL TRIALS. 2010;11(3): 163-169. Article. 1,835 Q3
2010 Fox, J.; Peters, B., Prakash, M.; Arribas, J.; Hill, A.; Moecklinghoff, C. Improvement in vitamin D deficiency following antiretroviral regime change: Results from the MONET trial. AIDS RESEARCH AND HUMAN RETROVIRUSES. 2010; 27(1): 29-34. Article. 2,082 Q3
2010 Martínez, E.; Larrousse, M.; Podzamczer, D.; Pérez, I.;, Gutiérrez, F.; Loncá, M.; Barragán, P.; Deulofeu, R.; Casamitjana, R.; Mallolas, J.; Pich, J.; Gatell, J. M.; BICOMBO Study Team. (JR Arribas miembro del grupo). Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction. AIDS 2010; 28(3): F1-9. Article. 6,348 Q1
2010 Llibre, J. M.; Antela, A.; Arribas, J. R.; Domingo, P.; Gatell, J. M.; López-Aldeguer, J.; Lozano, F.; Miralles, C.; Molto, J.; Moreno, S.; Ortega, E.; Riera, M.; Rivero, A.; Villalonga, C.; Clotet, B. Role of fixed-dose combinations of antiretrovirals in HIV-1 therapy. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2010; 28(9): 615-620. Review. 1,656 Q3
2010 Moreno, S.; Aldeguer, J. L.; Arribas, J. R.; Domingo, P.; Iribarren, J. A.; Ribera, E.; Rivero, A.; Pulido, F. The future of antiretroviral therapy: challenges and needs. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2010; 65(5): 827-835. Review. 4,659 Q1
2010 de la Serna, J. I. B.; Zamora, F. X.; Montes, M. L.; García-Puig, J.; Arribas, J. R. Hypertension, HIV infection, and highly active antiretroviric therapy. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2010; 28(1): 32-37. Review. 1,656 Q3
2010 del Rosal, T.; Baquero-Artigao, F.; García-Miguel, M. J.; Méndez-Echevarría, A.; López, G.; Aracil, F. J.; de Jose, M. I.; del Castillo, F. Impact of Immigration on Pulmonary Tuberculosis in Spanish Children A Three-Decade Review. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2010; 29(7): 648-651. Review. 3,064 Q1
2010 Rico, A.; Paño, J. R.; Cruz, A. Chronic osteomyelitis of the foot. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLINÍCA. 2010; 28(3): 200-202. Editorial Material. 1,656 Q3
2010 Pareja, J. F.P.; García, J. G.; Montes, M. L.; Arribas, J. R. Liver steatosis and body fat in patients coinfected by human immunodeficiency and hepatitis C virus Reply. MEDICINA CLÍNICA. 2010; 134(4): 186-187. Letter. 1,413 Q2
2010 Cordon, J. P.; Senent, S. G.; Franco, J. D. E.; Merino, L. A.; Arranz, E. M.; Herranz, M. J.; Martínez, L. C.; Villegas, M. P.; Bujalance, S. G.; Pardo, J. R. P.; Cabral, J. M. S. Can Whipple's disease be diagnosed through PCR techniques? GASTROENTEROLOGIA Y HEPATOLOGIA 2010; 33(5): 412-413. Letter. No tiene No tiene
2010 Mora, M.; Rodríguez-Castellano, E.; Paño-Pardo, J. R.; González-García, J.; Navarro, C.; Figueira, J. C.; Arribas, J. R. Influenza A Pandemic (H1N1) 2009 Virus and HIV. EMERGING INFECTIOUS DISEASES. 2010; 16(7): 1175-1176. Letter. 6,859 Q1
2010 Pérez-Valero, I.; Zamora, F. X.; Pulido, F.; Arribas, J. R. Incorrect attribution of cerebrospinal fluid HIV-1 virological escape and lymphocytic meningitis to lopinavir/ritonavir monotherapy. AIDS. 2010; 24(15): 2415-2416. Letter. 6,348 Q1
2010 Arribas, J. R.; Pulido, F. Response to: "Assessment of Baseline HIV Viral Load as a Risk Factor for Loss of Virologic Suppression in Protease Inhibitor-Based Monotherapy Trials''. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2010; 53(5): 670-670. Letter. 4,262 Q1
2010 Rico, A.; Paño, J. R.; Romero, M. P. Salmonella typhi bacteremia after biliary stenting. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2010; 28 (5): 237-329. Letter. 1,656 Q3
2010 Paño-Pardo, J. R.; García, A.; Aracil, F.; Martínez, A. Community-associated methicillin-resistant Staphylococcus aureus disease in two members of a household in Spain. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2010; 28(7): 472-473. Letter. 1,656 Q3
2010 Arribas, J. R.; Rivero, A.; Leal, M.; Sánchez-de la Rosa, R. Human immunodeficiency virus (HIV) type 1 with R5 tropism among HIV-1 antiretroviral-experienced patients in Spain. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2010; 28(8): 559-560. Letter. 1,656 Q3
2010 de la Serna, J. I. B.; Montes, M. L.; Zamora, F. X. Outpatient blood pressure monitoring of the HIV patient reply. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA. 2010; (9): 665-665. Letter. 1,656 Q3
2009 Pascual-Pareja, JF; Caminoa, A; Larrauri, J; Gonzalez-Garcia, J; Montes, ML; Diez, J; Grande, M; Arribas, JR. HAART is associated with lower hepatic necroinflammatory activity in HIV-hepatitis C virus-coinfected patients with CD4 cell count of more than 350 cells/mu l at the time of liver biopsy. AIDS. 2009; 23(8): 971-975 4,909
Q1
2009 Pulido, F; Perez-Valero, I; Delgado, R; Arranz, A; Pasquau, J; Portilla, J; Rubio, R; Gonzalez-Garcia, J; Miralles, P; Perez-Elias, MJ; Ocampo, A; Hernando, A; Estrada, V; Clotet, B; Podzamczer, D; Arribas, JR. Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression. ANTIVIRAL THERAPY. 2009; 14(2): 195-201 4,322
Q1
2009 Cachafeiro, SP; Del Amo, J; Iribarren, JA; Lleti, MS; Gutierrez, F; Moreno, A; Labarga, P; Pineda, JA; Vidal, F; Berenguer, J; Moreno, S. Decrease in Serial Prevalence of Coinfection with Hepatitis C Virus among HIV-Infected Patients in Spain, 1997-2006. CLINICAL INFECTIOUS DISEASES. 2009; 48(10): 1467-1470 8,195
Q1
2009 Perez-Elias, MJ; Miguel, LGS; Garcia, JG; Ramirez, MLM; Muriel, A; Machin-Lazaro, JM; Martinez-Baltanas, A; Zamora, F; Moreno, A; Martin-Davila, P; Quereda, C; Gomez-Mampaso, E; Moreno, S. Tuberculosis Complicating Hepatitis C Treatment in HIV-Infected Patients. CLINICAL INFECTIOUS DISEASES. 2009; 48(8): E82-E85 8,195
Q1
2009 Arribas,J. R.. Drugs in traditional drug classes (nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor/protease inhibitors) with activity against drug-resistant virus (tipranavir, darunavir, etravirine). CURRENT OPINION IN HIV AND AIDS. 2009; 4(6): 507-512 No tiene
No tiene
2009 Rico, A; Pano-Pardo, JR; Montes, ML; Mingorance, J. An HIV-positive homosexual man with fever and a skin lesion. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2009; 27(7): 419-421 1,393
Q4
2009 Montes, ML; Fraile, JM; Gonzalez, JJ; Arribas, JR. Chorea during treatment with pegylated interferon and ribavirin in HIV-HCV coinfected patient. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2009; 27(1): 60-61 1,393
Q4
2009 Bernardino de la Serna,J. I.;Arribas Lopez,J. R.. Controversies and future of the approach to cardiovascular disease in HIV patients. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2009; 27 Suppl 1: 48-53 1,393
Q4
2009 Panel de expertos de Gesida y Plan Nacional sobre el Sida. Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009). ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2009; 27(4): 222-235 1,393
Q4
2009 Berenguer, J; Alvarez-Pellicer, J; Martin, PM; Lopez-Aldeguer, J; Von-Wichmann, MA; Quereda, C; Mallolas, J; Sanz, J; Tural, C; Bellon, JM; Gonzalez-Garcia, J. Sustained Virological Response to Interferon Plus Ribavirin Reduces Liver-Related Complications and Mortality in Patients Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus. HEPATOLOGY. 2009; 50(2): 407-413 10,840
Q1
2009 Pozniak, A; Gupta, RK; Pillay, D; Arribas, J; Hill, A. Causes and Consequences of Incomplete HIV RNA Suppression in Clinical Trials. HIV CLINICAL TRIALS. 2009; 10(5): 289-298 1,626
Q3
2009 Patel, D; Thorne, C; Newell, ML; Cortina-Borja, M; Giaquinto, C; Rampon, O; D'Elia, R; De Rossi, A; Grosch-Worner, I; Mok, J; de Jose, MI; Martinez, BL; Pena, JM; Garcia, JG; Lopez, JRA; Garcia-Rodriguez, J; Asensi-Botet, F; Otero, MC; Perez-Tamarit, D; S. Levels and patterns of HIV RNA viral load in untreated pregnant women. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2009; 13(2): 266-273 2,167
Q3
2009 Pano-Pardo,J. R.;Alcaide,M. L.;Abbo,L.;Dickinson,G.. Primary HIV infection with multisystemic presentation. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2009; 13(4): e177-80 2,167
Q3
2009 Martinez, E; Arranz, JA; Podzamczer, D; Lonca, M; Sanz, J; Barragan, P; Ribera, E; Knobel, H; Roca, V; Gutierrez, F; Blanco, JL; Mallolas, J; Llibre, JM; Clotet, B; Dalmau, D; Segura, F; Arribas, JR; Cosin, J; Barrufet, P; Casas, E; Ferrer, E; Curran, A;. A Simplification Trial Switching From Nucleoside Reverse Transcriptase Inhibitors to Once-Daily Fixed-Dose Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1-Infected Patients With Virological Suppression. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2009; 51(3): 290-297 4,207
Q1
2009 Domingo, P; Suarez-Lozano, I; Torres, F; Pomar, V; Ribera, E; Galindo, MJ; Cosin, J; Garcia-Alcalde, ML; Vidal, F; Lopez-Aldeguer, J; Roca, B; Gonzalez, J; Lozano, F; Garrido, M. Bacterial Meningitis in HIV-1-infected Patients in the Era of Highly Active Antiretroviral Therapy. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2009; 51(5): 582-587 4,207
Q1
2009 Sension, M; Neto, JLD; Grinsztejn, B; Molina, JM; Zavala, I; Gonzalez-Garcia, J; Donnelly, A; Phiri, P; Ledesma, E; McGrath, D. Improvement in Lipid Profiles in Antiretroviral-Experienced HIV-Positive Patients With Hyperlipidemia After a Switch to Unboosted Atazanavir. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2009; 51(2): 153-162 4,207
Q1
2009 Arribas, JR; Delgado, R; Arranz, A; Munoz, R; Portilla, J; Pasquau, J; Perez-Elias, MJ; Iribarren, JA; Rubio, R; Ocampo, A; Sanchez-Conde, M; Knobel, H; Arazo, P; Sanz, J; Lopez-Aldeguer, J; Montes, ML; Pulido, F. Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2009; 51(2): 147-152 4,207
Q1
2009 Garriga, C; Perez-Elias, MJ; Delgado, R; Ruiz, L; Perez-Alvarez, L; Pumarola, T; Lopez-Lirola, A; Gonzalez-Garcia, J; Menendez-Arias, L. HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2009; 64(2): 251-258 4,352
Q1
2009 Berenguer, J; Gonzalez-Garcia, J; Lopez-Aldeguer, J; Von-Wichmann, MA; Quereda, C; Hernando, A; Sanz, J; Tural, C; Ortega, E; Mallolas, J; Santos, I; Miralles, P; Montes, ML; Bellon, JM; Esteban, H. Pegylated interferon alpha 2a plus ribavirin versus pegylated interferon alpha 2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2009; 63(6): 1256-1263 4,352
Q1
2009 Pareja, JFP; Montes, ML; Gonzalez-Garcia, J; Arribas, JR. Spontaneous Viral Clearance, Viral Load, and Genotype Distribution of Hepatitis C Virus (HCV) in European HIV-Infected Patients with Anti-HCV Antibodies. JOURNAL OF INFECTIOUS DISEASES. 2009; 199(10): 1556-1557 5,865
Q1
2009 Pareja, JFP; Camino, A; Larrauri, J; Lopez-Dieguez, M; Montes, ML; Gonzalez-Garcia, J; Pena, JM; Diez, J; Arribas, JR. Factors associated with hepatic steatosis in human immunodeficiency virus and hepatits C virus coinfected patients. MEDICINA CLINICA. 2009; 132(6): 208-213 1,231
Q3
2009 Arribas, JR; Mora, M; Pascual-Pareja, JF. Early versus Deferred Antiretroviral Therapy for HIV. NEW ENGLAND JOURNAL OF MEDICINE. 2009; 361(8): 823-823 47,050
Q1
2009 Abrams, D; Levy, Y; Losso, MH; Babilker, A; Collins, G; Cooper, DA; Darbyshire, J; Emery, S; Fox, L; Gordin, F; Lane, HC; Lundgren, JD; Mitsuyasu, R; Neaton, JD; Phillips, A; Routy, JP; Tambussi, G; Wentworth, D. Interleukin-2 Therapy in Patients with HIV Infection. NEW ENGLAND JOURNAL OF MEDICINE. 2009; 361(16): 1548-1559 47,050
Q1